Company news

Ondine Biomedical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

Notification of major holdings

November 18, 2024

Final Result of Fundraise & TVR

November 15, 2024

Updated Result of Fundraise

November 14, 2024

Update on Private Placement and Placing

November 11, 2024

Result of Fundraise

November 1, 2024

Related Party Transaction

October 30, 2024

Ondine continues commercial growth

October 28, 2024

King’s College Hospital to run Steriwave pilot

October 23, 2024

Steriwave receives UAE Regulatory Approval

October 18, 2024

Ondine Biomedical Reports Robust Growth in H1 2024

September 30, 2024

Collaboration advances Steriwave for ICU Market

September 25, 2024

Ondine secures C$5 million financing

September 24, 2024

Mölnlycke® and Ondine Join Forces Against HAIs

September 23, 2024

Ondine announces Board Changes

September 16, 2024

Steriwave in British Columbia Health Authorities

August 23, 2024

Leeds Teaching Hospital NHS Trust to use Steriwave

August 6, 2024

Result of AGM and Voting Results

June 28, 2024

Steriwave now available through NHS Supply Chain

June 21, 2024

2023 Full Year Results and Annual Report

June 7, 2024

Notice of AGM and Directorate Change

June 6, 2024

Notice of Results, Investor Presentation, and AGM

May 28, 2024

ECDC report shows rising HAIs and antibiotic use

May 10, 2024

Further Result of Fundraising

May 8, 2024

Result of Fundraising

May 3, 2024

Related Party Transactions

May 2, 2024

New study confirms nose is key source of infection

April 25, 2024

Corporate and Trading Update

April 24, 2024

Steriwave in first Australian hospital

April 22, 2024

32% Fewer SSIs After Steriwave Replaced Mupirocin

April 15, 2024

Steriwave authorized for use by HCA UK

April 10, 2024

Entry into ICU market expands revenue potential

April 4, 2024

Appointment of Interim Chief Financial Officer

March 28, 2024

First commercial adoption of Steriwave by the NHS

March 25, 2024

Steriwave study shows 77% drop in antibiotic use

March 21, 2024

Replacement: Steriwave deploying in 8 new sites

March 15, 2024

Ondine starts first UK health economics study

March 5, 2024

Microbiome research supports use of Steriwave

January 31, 2024

Ondine unveils new research at SPIE Photonics West

January 26, 2024

Ondine Biomedical - Appointment of new Chief Financial Officer

January 17, 2024

Appointment of new Chief Financial Officer

January 16, 2024

C$4.91 raise supports ongoing commercialisation

December 13, 2023

TR-1: notification of major holdings

December 12, 2023

Result of Placing & Broker Option Update

December 5, 2023

Close of Bookbuild

December 4, 2023

Update. Re investor-led financing

December 1, 2023

Ondine announces investor-led financing

November 30, 2023

Photodisinfection recommended as Standard of Care

November 16, 2023

Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR

November 13, 2023

Steriwave use expanded following successful pilot

October 31, 2023

66.5% reduction in spine surgery infection rate

October 23, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.